ARCHIVES

Clinical Trials: For ER+ Breast Cancer, Post-Tamoxifen, NSABP Testing Aromasin In Large Trial

This article is from The Cancer Letter archive.

Vol. 27 No. 22 | June 1, 2001

Download PDF Visit The Full Archive

Related Articles

Byrd Permits NCI to Reallocate WVU Money

June 21, 1985

Ellence Has Lower Risk Of Heart Damage, Study Finds

August 27, 2004

NCI To Fund 23 CHOPs, More Singles Than Multiples; ACCC Expresses Concern

August 8, 1980

NCI Programs: 15 New Grants Awarded In Survivor Research

October 9, 1998

FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.

March 1, 2002

Dana-Farber And Merck To Collaborate On Therapeutics.

February 15, 2008